DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
McCormack FX, Inoue Y, Moss J. et al.
National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
N Engl J Med 2011;
364: 1595-1606
We do not assume any responsibility for the contents of the web pages of other providers.